Management at footwear retailer DSW (NYSE: DSW ) raised guidance 5.5% for the full year to $3.60 to $3.80 per share, and said it would split its Class A stock 2-for-1.
If approved by shareholders, DSW will issue one share of Class A stock for each Class A or Class B share outstanding. The split is expected to create a total of approximately 90.2 million shares, comprised of approximately 81.6 million Class A shares, which�will continue to hold one vote per share,�and 8.6 million Class B shares, which�will hold eight votes per share, with the�voting control of the Class B shareholders reduced from 65% to approximately 46% post-split.
The split was brought about as a result of second-quarter revenues jumping 9% from the year-ago period to $558 million as same-store sales rose 4.3% year over year with the anticipation they would continue to grow in the low-single-digit range.
In conjunction with the stock split, the board will also seek�an amendment to allow DSW to increase the number of authorized Class A shares from 170 million to 250 million.
Best Building Product Stocks To Invest In Right Now: Astivita Renewables Limited(AIR.AX)
AstiVita Renewables Limited, through its subsidiaries, imports, warehouses, and distributes bathroom, kitchen, and solar products for retailers, plumbing merchants, hardware suppliers, and licensed dealers in Australia and New Zealand. It offers tap ware, bath spouts, shower heads, bathroom vanities, baths and spas, basins, shower cubicles, bathroom accessories, mirrors and cabinets, bathroom toilets, plugs and wastes, kitchen sinks, kitchen appliances, and solar hot water and home solar electricity products. AstiVita Renewables Limited was founded in 2004 and is based in Rocklea, Australia.
Best Building Product Stocks To Invest In Right Now: China Minzhong Food Corp Ltd (K2N.SI)
China Minzhong Food Corporation Limited, an investment holding company, operates as an integrated vegetable processing company. It cultivates, produces, and sells processed and fresh vegetables. The company�s processed vegetables include air-dried, freeze-dried, fresh-packed, and brined products, as well as fruit and vegetable juices, vermicelli, water-boiled vegetables, and other products. It also offers fresh vegetable products and mushroom spores. The company sells its products in 26 countries and regions, including the Americas, Asia, and Europe. China Minzhong Food Corporation Limited was founded in 1971 and is headquartered in Putian, the People's Republic of China.
Best Safest Companies To Watch In Right Now: Galena Biopharma Inc (GALE)
Galena Biopharma, Inc. (Galena), formerly RXi Pharmaceuticals Corporation, incorporated on April 3, 2006, is a biotechnology company focused on discovering, developing and commercializing therapies addressing unmet medical needs using targeted biotherapeutics. The Company is pursuing the development of cancer therapeutics using peptide-based immunotherapy products, including its main product candidate, NeuVaxTM (E75), for the treatment of breast cancer and other tumors. NeuVax is a peptide-based immunotherapy intended to reduce the recurrence of breast cancer in low-to-intermediate HER2-positive breast cancer patients not eligible for trastuzumab (Herceptin; Genentech/Roche). On January 19, 2012, the Company initiated enrollment in its Phase 3 PRESENT clinical trial for NeuVax (E75 peptide plus GM-CSF) vaccine in low-to-intermediate HER2 1+ and 2+ breast cancer patients in the adjuvant setting to prevent recurrence (Clinicaltrials.gov identifier NCT01479244). The Prevention of Recurrence in Early-Stage, Node-Positive Breast Cancer with Low to Intermediate HER2 Expression with NeuVax Treatment study is a randomized, multicenter, multinational clinical trial that will enroll approximately 700 breast cancer patients. The Company�� Phase 2 trial of NeuVax achieved its primary endpoint of disease-free survival (DFS). On April 13, 2011, the Company completed its acquisition of Apthera, Inc.,(Apthera).
The Company focuses to start a Phase 2 trial comparing NeuVax in combination with trastuzumab (Herceptin) versus trastuzumab, alone, in a 300-patient, randomized study in the adjuvant breast cancer setting. The Company's second product candidate, Folate Binding Protein-E39 (FBP), is a vaccine, consisting of the peptides E39 and J65, aimed at preventing the recurrence of ovarian, endometrial, and breast cancers. On February 14, 2012, the Company announced the initiation of a Phase 1/2 clinical trial in two gynecological cancers: ovarian and endometrial adenocarcinomas. Folate binding protein has ! very limited tissue distribution and expression in non-malignant tissue and is over-expressed in more than 90% of ovarian and endometrial cancers, as well as in 20% to 50% of breast, lung, colorectal and renal cell carcinomas.
In April 2011, the Company acquired Apthera Inc and its NeuVax product candidate. The Company focuses on developing a pipeline of immunotherapy product candidates for the treatment of various cancers based on the E75 peptide, the advanced of which is NeuVax, which is targeted at preventing the recurrence of breast cancer. NeuVax has had positive Phase 1/2 clinical trial results for the prevention of breast cancer recurrence in patients who have had breast cancer and received the standard of care treatment (surgery, chemotherapy, radiotherapy and hormonal therapy as indicated). The Company had also initiated its Phase 3 PRESENT clinical trial of NeuVax for the prevention of breast cancer recurrence in early-stage low-to-intermediate HER2 breast cancer patients. NeuVax directs killer T-cells to target and destroy cancer cells that express HER2/neu, a protein associated with epithelial tumors in breast, ovarian, pancreatic, colon, bladder and prostate cancers. NeuVax is comprised of a HER2/neu-derived peptide called E75. E75 is a nine-amino acid sequence that is immunogenic (produces an immune response) and GM-CSF is a commercially available protein that acts to stimulate and activate components of the immune system such as macrophages and dendritic cells.
The Company also develops novel applications for NeuVax based on preclinical studies and phases 2 clinical trials which suggest that combining NeuVax and trastuzumab (Herceptin; Genentech/Roche) can increase antigen presentation by tumor cells by promoting receptor internalization and subsequent proteosomal degradation of the HER2 protein. The Company also is pursuing additional therapeutic indications for NeuVax that are in Phase 1/2 clinical trials. RXI-109, is a dermal anti-scarring therapy that targets! connecti! ve tissue growth factor (CTGF) and that may inhibit connective tissue formation in human fibrotic disease.
The Company competes with Roche Laboratories, Inc., Pfizer Inc., Bayer HealthCare AG, Sanofi-Aventis, US, LLC, Amgen, Inc., GlaxoSmithKline plc, Renovo Group plc, CoDa Therapeutics, Inc., Sirnaomics, Inc., FirstString Research, Inc., Merz Pharmaceuticals, LLC, Capstone Therapeutics, Halscion, Inc., Garnet Bio Therapeutics, Inc., AkPharma Inc., Promedior, Inc., Kissei Pharmaceutical Co., Ltd., Eyegene, Derma Sciences, Inc., Healthpoint Biotherapeutics, Pharmaxon, Excaliard Pharmaceuticals, Inc., Alnylam Pharmaceuticals, Inc., Marina Biotech, Inc., Tacere Therapeutics, Inc., Benitec Limited, OPKO Health, Inc., Silence Therapeutics plc, Quark Pharmaceuticals, Inc., Rosetta Genomics Ltd., Lorus Therapeutics, Inc., Tekmira Pharmaceuticals Corporation, Arrowhead Research Corporation, Regulus Therapeutics Inc. and Santaris.
Advisors' Opinion:- [By James E. Brumley]
It may look like little more than a choppy mess with just a quick glance at Galena Biopharma Inc. (NASDAQ:GALE). But, the more you study the chart - and the company - the more you realize there's enough long-term potential from the company's pipeline to keep spurring GALE in a generally-upward direction. In fact, the bulls look like they're on the verge of taking Galena Biopharma out of second gear and putting it into third. As such, it may not be a bad bet at this point.
- [By Paul Ausick]
Stocks on the move: Galena Biopharma Inc. (NASDAQ: GALE) is down 15.4% at $1.93 after pricing a secondary offering of 17.5 million units at $2.00. Safeway Inc. (NYSE: SWY) is up 6.1% at $28.21, after an analyst�� upgrade which sent shares to a new 52-week high of $28.88 earlier. Avanir Pharmaceuticals Inc. (NASDAQ: AVNR) is down 18.2% at $4.08.
- [By Sean Williams]
The waiting game
The tables are clearly stacked against small biotech companies developing cancer drugs. History has shown that few (if any) have successfully had the Food and Drug Administration approve a late-stage cancer drug. While mid-stage trials of Galena Biopharma's (NASDAQ: GALE ) HER2-targeting breast cancer vaccine have been promising thus far, the chances of an approval seem a long way off.
Best Building Product Stocks To Invest In Right Now: HCC Insurance Holdings Inc. (HCC)
HCC Insurance Holdings, Inc. underwrites non-correlated specialty insurance products worldwide. The company operates in five segments: U.S. Property & Casualty, Professional Liability, Accident & Health, U.S. Surety & Credit, and International. The U.S. Property & Casualty segment provides aviation, small account errors and omissions liability (E&O), public risk, contingency, disability, residual value, employment practices liability (EPLI), technical property, primary and excess casualty, and brown water marine insurance products, as well as title and mortgage reinsurance products in the United States. The Professional Liability segment offers directors� and officers� (D&O) liability, large account E&O liability, fiduciary liability, fidelity and bankers blanket bonds, and EPLI for the United States and International-based policyholders. The Accident & Health segment provides medical stop-loss, short-term domestic and international medical, HMO reinsurance, and medical excess coverages in the United States. The U.S. Surety & Credit segment offers contract surety bonds, commercial surety bonds, and bail bonds; credit insurance policies for export trade transactions and structured trade transactions; and political risk and letters of credit insurance products. The International segment provides energy, property treaty, liability, surety, credit, direct and facultative property, ocean marine, accident and health, and other smaller product lines for international customers. The company markets its products directly to consumers, as well as through a network of independent agents and brokers, producers, and managing general agents. HCC Insurance Holdings, Inc. was founded in 1974 and is headquartered in Houston, Texas.
Advisors' Opinion:- [By WWW.GURUFOCUS.COM]
HCC Insurance Holdings Inc. (HCC) underwrites non-correlated specialty insurance products worldwide. The company operates in five segments: U.S. Property and Casualty, Professional Liability, Accident and Health, U.S. Aug. 21, the company increased its quarterly dividend 36% to $0.225 per share. The dividend is payable October 1, 2013 and will be paid on or about Oct. 15, 2013. The yield based on the new payout is 2.1%.
Best Building Product Stocks To Invest In Right Now: Angoss Software Corp. (ANC.V)
Angoss Software Corporation provides predictive analytics software and solutions primarily to financial services, insurance, retail, health care, and information communication and technology organizations. The company�s products include KnowledgeHUB, a cloud-based analytical platform that combines technologies with deployment processes and professional services, which allows clients to convert analytical insight into action; KnowledgeCLOUD industry solutions, through KnowledgeHUB, deliver predictive analytics in the cloud for organizations in the areas of sales, marketing, and risk management; and KnowledgeSCORE, a cloud-based predictive sales analytics solution for customer relationship management. Its products also comprise KnowledgeEXCELERATOR, a visual data discovery and prediction tool for business analysts and knowledge workers; and KnowledgeSTUDIO, a predictive analytics solution, which along with text analytics integration enables mining and analyzing unstructured data, such as social media, call center logs, emails, and other forms of text-based communications, as well as KnowledgeSERVER, a deployment platform. In addition, the company offers other predictive analytics software, including KnowledgeSEEKER and StrategyBUILDER; and data mining consulting, engineering, and user-training services. It primarily operates in North America and Europe. Angoss Software Corporation is based in Toronto, Canada.
Best Building Product Stocks To Invest In Right Now: Starwood Hotels & Resorts Worldwide Inc.(HOT)
Starwood Hotels & Resorts Worldwide Inc. operates as a hotel and leisure company worldwide. The company operates luxury and upscale full service hotels, select-service hotels, extended stay hotels, resorts, retreats, and residences under St. Regis, The Luxury Collection, W, Westin, Le M�idien, Sheraton, Four Points, Aloft, and Element brand names. It also engages in the development and operation of vacation ownership resorts; marketing and selling vacation ownership interests in the resorts; and provision of financing to customers who purchase such interests. In addition, the company develops, markets, and sells residential units at mixed use hotel projects. As of December 31, 2011, its hotel portfolio included 1,076 owned, managed, or franchised hotels with approximately 315,300 rooms; and 13 stand-alone vacation ownership resorts and residential properties. The company was founded in 1969 and is headquartered in Stamford, Connecticut. Starwood Hotels & Resorts Worldwid e Inc. operates independently of ITT Corporation as of December 19, 1995.
Advisors' Opinion:- [By Matt Thalman]
In the following video, Fool contributor Matt Thalman discusses a few metrics and areas investors should focus their attention on when looking at Starwood's (NYSE: HOT ) upcoming earnings report.
- [By Sarah Jones]
Hochtief AG (HOT) advanced 5.9 percent to 56.51 euros. Germany�� largest construction company agreed to sell its airports division to Public Sector Pension Investment Board of Canada for about 1.5 billion euros as it streamlines its business to focus on more profitable units.
Best Building Product Stocks To Invest In Right Now: Shore Gold Inc Com Npv (SGF.TO)
Shore Gold Inc., an explorations stage company, engages in the acquisition, exploration, and development of mineral properties. It principally explores for diamond. The company primarily focuses on the exploration of the Star � Orion South diamond project located in the Fort � la Corne Provincial Forest, Saskatchewan, Canada. It also holds a 33% interest in the Buffalo Hills property located in northern Alberta, Canada. The company was formerly known as Shore Gold Fund Inc. and changed its name to Shore Gold Inc. in August 1994. Shore Gold Inc. was incorporated in 1985 and is headquartered in Saskatoon, Canada.
Best Building Product Stocks To Invest In Right Now: Amazon.com Inc.(AMZN)
Amazon.com, Inc. operates as an online retailer in North America and internationally. It operates retail Web sites, including amazon.com and amazon.ca. The company serves consumers through its retail Web sites and focuses on selection, price, and convenience. It also offers programs that enable sellers to sell their products on its Web sites, and their own branded Web sites. In addition, the company serves developer customers through Amazon Web Services, which provides access to technology infrastructure that developers can use to enable virtually various type of business. Further, it manufactures and sells the Kindle e-reader. Additionally, the company provides fulfillment; miscellaneous marketing and promotional agreements, such as online advertising; and co-branded credit cards. Amazon.com, Inc. was founded in 1994 and is headquartered in Seattle, Washington.
Advisors' Opinion:- [By Chuck Saletta]
Wal-Mart (NYSE: WMT ) recently announced that it was adding lockers to many of its stores to enable same-day pickup of items ordered online. In this video, Fool contributor Chuck Saletta talks about how that strategy copycats one that Amazon.com (NASDAQ: AMZN ) has already launched and notes that if Wal-Mart really wants to win, it needs to think leapfrog instead.
Best Building Product Stocks To Invest In Right Now: Los Andes Copper Ltd. (LA.V)
Los Andes Copper Ltd. engages in the identification, acquisition, exploration, and development of mineral properties in Latin America. It focuses on the Vizcachitas porphyry copper�molybdenum project located 120 kilometers north of Santiago, Region V, Chile. The company is headquartered in Vancouver, Canada.
No comments:
Post a Comment